Fosravuconazole
- Generic Name
- Fosravuconazole
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H20F2N5O5PS
- CAS Number
- 351227-64-0
- Unique Ingredient Identifier
- L4Q6O5430L
- Background
Fosravuconazole is under investigation in clinical trial NCT03378661 (BENDITA BEnznidazole New Doses Improved Treatment and Associations).
- Associated Conditions
- -
- Associated Therapies
- -
Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan
- First Posted Date
- 2017-03-22
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Drugs for Neglected Diseases
- Target Recruit Count
- 104
- Registration Number
- NCT03086226
- Locations
- 🇸🇩
Mycetoma Research Centre, Khartoum, Sudan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath